Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02230839 · ClinicalTrials.gov registry record · NA
Muscle Insulin Resistance in Aging (Mirage)
A NA study of Insulin Resistance and Sarcopenia, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT02230839 is a NA study of Insulin Resistance and Sarcopenia that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 200 participants, below the 244-participant average among 120 other Insulin Resistance trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02230839, a NA study of Insulin Resistance and Sarcopenia, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to provide information regarding potential factors underlying metabolic dysfunction, insulin resistance, and loss of muscle mass in aging muscle.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Energy Restriction-Induced Weight Loss
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2014-06 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02230839
The ClinicalTrials.gov registry entry for NCT02230839 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 120 other Insulin Resistance trials with a reported enrollment target (18% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT02230839 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02230839 about?
NCT02230839 is a clinical study titled "Muscle Insulin Resistance in Aging (Mirage)". The purpose of this study is to provide information regarding potential factors underlying metabolic dysfunction, insulin resistance, and loss of muscle mass in aging muscle.
What is the current status of trial NCT02230839?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2014-06. Estimated completion is 2025-12.
What conditions does trial NCT02230839 study?
This clinical trial studies the following conditions: Insulin Resistance, Sarcopenia.
What interventions are being tested in trial NCT02230839?
The interventions under investigation include: Exercise (BEHAVIORAL), Energy Restriction-Induced Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT02230839?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02230839 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.